Propofol

丙泊酚

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NamePropofol
Drug Alias Name普鲁泊福propofolum异丙酚AmpofolDisoprivan +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[32
Global Approved IndicationsSedationAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved Date1989/10/02
Country/TerritoryBelgiumCanadaUnited States +[12
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active IndicationsSedationDepressive Disorder, Treatment-ResistantDepression +[15
Inactive IndicationsDepressive Disorder, MajorDrug-Related Side Effects and Adverse ReactionsShock +[17

Other Information

ATC CodeN01AX10